Can you please specify exactly "who" AMBS is falling behind regarding an ALZ blood based bio-marker assay that may have multiple dianostic abilities, not only for ALZ but for Traumatic Brain Injury (TBI) and Chronic Traumatic Encephalopathy (CTE).

I'd really like to know who you are speaking about Sir....

Quote:

---

Well, the main reason to be disappointed being that we are falling behind. Let me explain it. We've seen during the past few months that others are also developing blood tests for Alzheimer's so I personally think that time to market is critical.

---